Second Affiliated Hospital of Nanchang University
154
54
64
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.6%
1 terminated/withdrawn out of 154 trials
95.8%
+9.3% vs industry average
12%
18 trials in Phase 3/4
0%
0 of 23 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (154)
Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model "PANDAPro"
Role: collaborator
Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients
Role: collaborator
Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China
Role: collaborator
Early Lumbar Drainage for Intraventricular Hemorrhage
Role: lead
Deep Sedation vs. General Anesthesia for Pulsed Field Ablation in Atrial Fibrillation
Role: lead
The Effect of Perioperative Transcutaneous Electrical Acupoint Stimulation Combined With Traditional Chinese Medicine on Gastrointestinal Function Recovery in Patients Undergoing Abdominal Surgery
Role: collaborator
Phase II, Single-arm Exploratory Clinical Study of Tislelizumab Combined With Anlotinib in the Treatment of Advanced Pulmonary Pleomorphic Carcinoma
Role: lead
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
Phenotypic Age Acceleration (PhenoAgeAccel) for Joint Prediction of Disease Risk, Mortality Risk, Life Expectancy, and Disease-Free Healthspan in Major Chronic Diseases
Role: lead
Research on the Application of Nursing Intervention Based on ITHBC Theory in Postoperative Self-Management of Patients With Varicose Veins of the Lower Extremities
Role: lead
Hemorrhage Stroke Decision Making Model Based Deep Learning (BrainHemoAI System)
Role: lead
Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)
Role: lead
SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors
Role: lead
Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC
Role: lead
Multi-Center Registry Cohort Study on Prognostic Factors and Prediction Model Construction in Aneurysmal SAH
Role: lead
Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC
Role: lead
Clinical Study of Esketamine in Patients With Sepsis Undergoing Invasive Mechanical Ventilation
Role: lead
Study on the Diagnostic Efficacy of ICL Selection and Prediction Depth Model Based on Eye Images
Role: lead
Diagnostic Efficacy of CNN in Predicting Intraoperative Complications and Postoperative Outcomes in SMILE
Role: lead
Digital Remote Management Versus Usual Care for Optimization of Guideline-directed Medical Therapy in Patients With Heart Failure and Reduced Ejection Fraction: a Multicentre, Randomised, Controlled Trial (DigiCare-HFrEF)
Role: collaborator